Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients.

Blood - 1 Feb 2002

Yamaguchi Motoko, Seto Masao, Okamoto Masataka, Ichinohasama Ryo, Nakamura Naoya, Yoshino Tadashi, Suzumiya Junji, Murase Takuhei, Miura Ikuo, Akasaka Takashi, Tamaru Jun-ichi, Suzuki Ritsuro, Kagami Yoshitoyo, Hirano Masami, Morishima Yasuo, Ueda Ryuzo, Shiku Hiroshi, Nakamura Shigeo

Abstract excerpt

De novo CD5+ diffuse large B-cell lymphoma (CD5+ DLBCL) is known to have phenotypically and genotypically different characteristics than CD5- DLBCL and mantle cell lymphoma (MCL). To further characterize CD5+ DLBCL, 109 patients with CD5+ DLBCL were reviewed, and the results were compared with those of 384 CD5- DLBCL and 128 cyclin D1+ MCL patients. Patients with CD5+ DLBCL showed a higher age distribution...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD5 Antigens
Share to Cyclin D1

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunohistochemistry

Share to Immunophenotyping

Share to Lymphoma, B-Cell

Share to Lymphoma, Large B-Cell, Diffuse

Share to Prognosis

Share to Treatment Outcome

Source

Identifiers

PMID: 11806981
DOI: 10.1182/blood.v99.3.815

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients.PMID 11806981Read ↗

De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients.Semantic proximity Read ↗

Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5- with CD10+ groups may constitute clinically relevant subtypes.Semantic proximity Read ↗

CD5-positive diffuse large B-cell lymphoma with an unusual phenotype: Cytoplasmic CD20 (+), surface CD20 (-).Semantic proximity Read ↗

Primary cardiac CD5-positive diffuse large B-cell lymphoma:A case report and review of literatureSemantic proximity Read ↗

Diffuse large B-cell lymphoma.Semantic proximity Read ↗

De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.Semantic proximity Read ↗

CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy.Semantic proximity Read ↗

Clinical features of de novo CD25(+) diffuse large B-cell lymphoma.Semantic proximity Read ↗

Mantle cell lymphoma pathology update in the 2016 WHO classificationSemantic proximity Read ↗

Identification of CD5/Cyclin D1 Double-negative Pleomorphic Mantle Cell Lymphoma: A Clinicopathologic, Genetic, and Gene Expression Study.Semantic proximity Read ↗

MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.Semantic proximity Read ↗

Somatic hypermutations in the VH segment of immunoglobulin genes of CD5-positive diffuse large B-cell lymphomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.